Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) Morgan Stanley 24th Annual Global Healthcare Conference
Review the key takeaways and the transcript of this earnings call.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
website. If you have further questions, please reach out to our Morgan Stanley representatives. Let's get started the session with Takeda. The speakers are Andy Plump, head of R&D, and Rhonda Pacheco- Thank you.
from U.S. business unit head. Thank you, Andy and Rhonda. Thank you for joining us today.
Yeah. Thank you. Great to be here.
Yeah. Thank you. Thank you.
Before starting our session, I'd like to say great gratitude to Andy. According to the couple of days ago press release, you are retiring from the current role. You have contributed more than 15 years at Takeda, and now you have built a huge pipeline franchise. Thank you for your great achievement in the last more than 10 years, and I'm a bit sorry. A bit faith. I'm so sorry for that.
Yeah. Well, thank you very much, Muraoka-san.
We've had a long time together.
Yeah. In all the quarterly earnings reports that we've been in together, you've asked me a lot of really hard questions.
It's not the reason I'm retiring, but it's an upside to not have to take your hard questions anymore. No, but thank you. It's been a privilege to serve in this role for the last 12 years. I have never had anything professionally in my life that's been like this. It's an amazing company, very strong values, rooted in very strong science, and I'm very confident in our future with Julie, with Rhonda, with our team.
with the pipeline that we have, and I know we'll talk about that. I'm around for the next eight to nine months.
Yeah so I'm really looking forward to seeing you through a number of activities, and then managing an effective transition.
Great. Thank you. Today, I will ask a lot to you about the pipeline.
Hard questions. More hard questions.
Okay. Thank you. Takeda has actually many pipelines.
For me, as an analyst, for the first time in the last 10 years to discuss a lot of pipelines with Takeda. In the last 10 years, the opportunities of talking about pipelines were not so much, but now you are in a big inflection point. I would like to ask a lot about pipeline. Before that, Andy, you are retiring. Julie Kim, as CEO, she has taken over the big responsibilities from Christophe as well. It is a big changing phase for your companies. My question is capital market today to be set in December of this year. It is for her, big opportunities for explaining her new challenge going forward. My question is, what to be changed from the capital market today?
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Access every statement, the English original, and speaker-by-speaker history with StockNow Pro.
View the full transcript with ProCall participants
3 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring